[{"id":"409da099-f4a0-4d19-8f1c-da9bf68bdd78","acronym":"DIAMOND-01","url":"https://clinicaltrials.gov/study/NCT03008187","created_at":"2021-05-17T08:53:01.393Z","updated_at":"2024-07-02T16:35:04.730Z","phase":"Phase 1/2","brief_title":"SEL24/MEN1703 in Patients With Acute Myeloid Leukemia","source_id_and_acronym":"NCT03008187 - DIAMOND-01","lead_sponsor":"Menarini Group","biomarkers":" IDH1 • IDH2","pipe":" | ","alterations":" IDH2 mutation","tags":["IDH1 • IDH2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH2 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dapolsertib (MEN1703)"],"overall_status":"Completed","enrollment":" Enrollment 73","initiation":"Initiation: 03/10/2017","start_date":" 03/10/2017","primary_txt":" Primary completion: 04/13/2023","primary_completion_date":" 04/13/2023","study_txt":" Completion: 04/13/2023","study_completion_date":" 04/13/2023","last_update_posted":"2024-05-09"}]